Clinical trial
Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir…
NCT00146328 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00146328 |
|---|---|
| Title | Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects |
| Official title | A Long Term Open Label Rollover Trial Assessing the Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV-1 Infected Subjects |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Tipranavir |
| Enrollment | 997 |
| Start date | Apr 1, 2001 |
| Primary completion | May 1, 2008 |
| First posted | Sep 7, 2005 |
| Last update posted | Mar 6, 2014 |
| Countries | Argentina, Australia, Austria, Belgium, Brazil, Canada, Denmark, France, Germany, Greece, Italy, Mexico and 6 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: